BioXcel Therapeutics, Inc. Class Action Lawsuit The BioXcel class action lawsuit seeks to represent purchasers or acquirers of BioXcel Therapeutics, Inc. (NASDAQ: BTAI) securities between December 15, 2021 and June 28, 2023, inclusive (the “Class Period”). Captioned Martin v. BioXcel Therapeutics, Inc., No. 23-cv-00915 (D. Conn.), the BioXcel class action lawsuit charges BioXcel and certain of its top executive officers with violations of the Securities Exchange Act of 1934. If you suffered losses in BioXcel stock and wish to serve as lead plaintiff in the class action against BioXcel, please provide your information below. You can also contact BioXcel Stock Loss Lawyer Timothy L. Miles by calling 855/846-6529 or via e-mail at tmiles@timmileslaw.com. Lead plaintiff motions for the BioXcel lawsuit must be filed with the court no later than September 5, 2023.
from
https://www.youtube.com/watch?v=cIpq_H5UpO8
No comments:
Post a Comment